NHF announces more subsidies for cardiovascular medications

Jamaica's National Health Fund (NHF) has significantly boosted subsidies for 18 cardiovascular drug items, with increases per tablet or capsule ranging from $40 to more than $200.

These updated subsidies offer immediate financial relief to patients prescribed critical medications for cholesterol-lowering, lipid regulation, ischemic heart disease, and hypertension. The NHF stated that these adjustments directly soften the impact of rising prices for beneficiaries.

This initiative builds on earlier efforts this year, during which the NHF added 11 new drug labels and increased subsidies for 207 hypertension drug items by an average of 10 to 20 percent. These measures ensure that hypertension subsidies now cover approximately 50 percent of the total medication cost, addressing the condition's prevalence within the NHFCard program and its role as a primary driver of cardiovascular disease.

Further enhancing cardiovascular care, Heart Failure was added to the NHFCard program in March 2026, covering over 253 medication items. Additionally, beneficiaries can now access annual subsidies of $7,500 for an echocardiogram and $1,750 for an electrocardiogram (ECG), strengthening the NHF's commitment to early detection, monitoring, and management of cardiovascular diseases.

NHF CEO Everton Anderson emphasized the fund's dedication to reducing financial barriers to critical healthcare. "Cardiovascular disease remains a primary health challenge facing Jamaican families, and addressing it effectively requires a deliberate, focused approach," Anderson said. "Our mandate has always been centered on reducing the financial barriers to critical healthcare."

These expanded subsidies are available at participating private pharmacies across Jamaica. The NHF's broader efforts include increasing coverage for chronic illnesses, adding new treatments for respiratory, gastrointestinal, and cancer-related conditions earlier this year.

“

Cardiovascular disease remains a primary health challenge facing Jamaican families, and addressing it effectively requires a deliberate, focused approach. Our mandate has always been centered on reducing the financial barriers to critical healthcare.